（文章来源：证券日报） 证券日报网讯国光股份10月9日发布公告，在公司回答调研者提问时表示，2025年6月29日，农业农村部 为了规范农药标签和说明书管理，发布925号公告，并宣布自2026年1月1日起实施。第925号公告规定， 同一个登记证号的农药产品应当标注同样的商标，以确保全国范围内销售产品使用商标的一致性。具体 而言，在符合《农药标签和说明书管理办法》第三十一条规定的前提下，同一登记证号的农药产品可以 根据实际需要标注一个或多个商标，但必须保持市场销售的同一登记证号的农药产品标注商标的一致 性。该公告对农药标签作出进一步规范，有利于保障农药质量，有利于维护公平竞争的农药市场秩序， 有利于保障广大种植户的合法权益，有利于促进农药产业健康持续发展。拥有优质登记证件的农药企业 将更具竞争优势，因此随着"一证一品"政策的实施，未来农药行业的市场集中度有望进一步提升。 ...

四川国光农化股份有限公司 投资者关系活动记录表 证券代码： 002749 证券简称：国光股份 四川国光农化股份有限公司投资者关系活动记录表 编号：2025-026 投资者关系 活动类别 ☑特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他（ ） 活动参与人员 中泰证券股份有限公司 孙颖、徐思博、张海丽、 龚怡芸 中欧基金管理有限公司 袁维德 国光股份 董事会秘书 颜铭 国光股份 证券事务代表 李超 国光股份 证券投资部副部长 向阳 时间 2025 年 9 月 30 日 地点 公司龙泉办公区 形式 电话会议 交流内容及具 体问答记录 问 1：植物生长调节剂与其他农药的主要区别有哪些？ 答：植物生长调节剂，又称植调剂，是根据植物内源激素的结 构、功能和作用原理，经过人工提取、合成的，能够调节植物生长 发育和生理功能的化学物质，对植物的生长发育起到与内源激素相 同的调节、控制以及诱导作用。在农药类别中，植调剂是较特殊的 一种。植调剂的"用量低、效果显著、投入产出比高"这一优势， 使得该类农药成为现代农业不可或缺的重要生产资料。 植调剂与其他农药（除草剂、杀虫剂、杀菌剂 ...

Sales Model - The company's main customers include agricultural distributors, landscaping companies, government procurement departments, large group users, and large-scale planting units, with the end consumers primarily being planters and landscaping maintenance units [3] - The sales model consists of two types: distributor sales and direct sales, with distributor sales being the primary method, following a "Company - Distributor - Retailer - Customer" model [3][4] Policy Impact - The "One Certificate, One Product" policy, effective from January 1, 2026, aims to standardize pesticide labels and ensure consistency in trademarks across products with the same registration number, which is expected to enhance market concentration in the pesticide industry [4] Pricing Strategy - The company's pricing strategy includes value-based pricing and cost-plus pricing, with price adjustments considering market competition, supply-demand relationships, and pricing goals [5] Development Strategy - The company focuses on internal growth through the development and sales of core products like plant growth regulators and water-soluble fertilizers, while also considering mergers and acquisitions for external growth [6] Dividend Plan - The 2025 semi-annual dividend plan proposes a cash dividend of 4.00 CNY per 10 shares (tax included), with a commitment to actively and sustainably return value to shareholders [6] Industry Position - As of June 2023, there are over 500 registered enterprises for plant growth regulators in China, with approximately 1,900 effective products. The company holds 150 registration certificates, accounting for 7.9% of the total and 20.5% of the top 35 enterprises [7] Raw Material Prices - The prices of upstream raw materials have remained stable since the second half of 2024, with little likelihood of significant fluctuations in the near future [7] Gross Margin Improvement - The increase in gross margin in the first half of 2025 compared to the same period in 2024 is attributed to a higher sales volume of high-margin products and lower raw material prices [8]

Group 1 - The core viewpoint of the article highlights the recent research conducted by Huamei International on Guoguang Co., which includes insights on the company's dividend plan and competitive advantages in the pesticide market [1] - Guoguang Co. plans to distribute a cash dividend of 4.00 yuan (including tax) for every 10 shares for the first half of 2025, indicating a commitment to shareholder returns over the next three years [1] - The "one certificate, one product" policy effective from January 1, 2026, will require pesticide products with the same registration certificate number to be labeled with the same trademark, enhancing product quality assurance and market order [1] - Guoguang Co. adjusts product prices based on competitive environment, supply-demand relationships, and end-user demand, with more frequent adjustments for competitive products [1] - To mitigate risks in overseas pesticide business and seize commercial opportunities, Guoguang Co. has signed a cultivation agreement with related party Yan Yaqi to develop overseas pesticide projects in Asia, Africa, and Latin America [1] Group 2 - Huamei International Investment Group Co., established in 2000, has a registered capital of 138 million yuan and is located in Tianhe District, Guangzhou [2] - The company obtained private fund management qualifications in 2015 and has established research centers in major cities including Beijing, Shanghai, Shenzhen, Guangzhou, and Hong Kong [2] - The investment research team comprises members from well-known public and private funds, as well as securities and futures institutions, indicating a wealth of research and investment experience [2]

Group 1 - The core viewpoint of the news is that Guoguang Co., Ltd. is planning to distribute a cash dividend of 4.00 yuan (including tax) for every 10 shares for the first half of 2025, indicating a commitment to shareholder returns over the next three years [1] - The "One Certificate, One Product" policy effective from January 1, 2026, mandates that pesticide products with the same registration certificate number must be labeled with the same trademark, which will enhance product quality assurance and market order [1] - Guoguang Co., Ltd. adjusts product prices based on competitive environment, supply-demand relationships of raw materials, and end-user demand, with more frequent adjustments for products in a competitive market [1] Group 2 - To mitigate risks in overseas pesticide business and seize commercial opportunities, Guoguang Co., Ltd. has signed a "Cultivation Agreement" with related party Mr. Yan Yaqi to cultivate overseas pesticide projects in Asia, Africa, and Latin America [1] - Guangzhou Ruimin Investment Management Co., Ltd. is a private equity fund management company focused on secondary market investments, with a rigorous investment research decision-making process and risk control system [2] - The company aims to discover undervalued listed companies through value investment principles and provides customized investment management services to achieve stable asset appreciation [2]

Group 1 - The core point of the news is that Cactus Asset Management has conducted research on Guoguang Co., which includes insights on its dividend plan and market strategies [1] - Guoguang Co. plans to distribute a cash dividend of 4.00 yuan (including tax) for every 10 shares in the first half of 2025, indicating a commitment to shareholder returns over the next three years [1] - The "one certificate, one product" policy effective from January 1, 2026, will require that pesticide products with the same registration certificate number be labeled with the same trademark, enhancing product quality and market order [1] - Guoguang Co. will adjust product prices based on competitive environment, supply-demand relationships, and end-user demand, with more frequent adjustments for competitive products [1] - To mitigate risks in overseas pesticide business, Guoguang Co. has signed a cultivation agreement with related party Yan Yaqi to develop overseas pesticide projects in Asia, Africa, and Latin America [1] Group 2 - Cactus Asset Management was established on April 27, 2015, in the Shanghai Free Trade Zone and is one of the first batch of enterprises registered after the expansion of the zone [2] - The core team of Cactus Asset Management possesses extensive experience in securities investment and aims to prioritize client interests while enhancing professional standards [2]

Group 1 - The core point of the news is that a well-known private equity firm, Zhengyuan Investment, has conducted research on a listed company, Guoguang Co., which plans to distribute a cash dividend of 4.00 yuan per 10 shares for the first half of 2025, indicating a commitment to shareholder returns over the next three years [1] - The "One Certificate, One Product" policy effective from January 1, 2026, mandates that pesticide products with the same registration certificate number must be labeled with the same trademark, which is expected to enhance product quality and market order, giving companies with quality registration certificates a competitive edge [1] - Guoguang Co. adjusts product prices based on competitive environment, supply-demand relationships, and end-user demand, with frequent adjustments for competitive products and stable prices for others [1] - To mitigate risks in overseas pesticide business and seize commercial opportunities, Guoguang Co. has signed a "Cultivation Agreement" with related party Mr. Yan Yaqi to develop overseas pesticide projects in Asia, Africa, and Latin America [1] Group 2 - Zhengyuan Investment, established in 2015 in the Qianhai Free Trade Zone of Shenzhen, holds a private securities investment fund license and has a professional investment research team with rich experience and a sound risk management system [2] - The firm focuses on China's economic structural transformation and upgrading, aiming to serve the development of the real economy by connecting social capital with quality industries, thereby achieving asset preservation and appreciation for clients [2]

Group 1 - Samsung has decided to extend the production of DDR4 DRAM until December 2026, reversing its earlier plan to cease production this year due to a surge in demand for DDR4 [2] - The second batch of 718 counterfeit Pop Mart toys was seized by customs, indicating ongoing issues with intellectual property rights in the toy industry [3] - Xincheng Capital has successfully raised over 4.5 billion RMB for a new merger and acquisition fund, aiming to leverage the advantages of the Yangtze River Delta industrial cluster [4] Group 2 - The departure of Yan Weixin, co-founder of Zhiyuan Robotics, may highlight potential discrepancies in the company's technological direction and its alignment with market needs [5] - Recent agricultural policies in China, such as "one certificate, one product," are expected to enhance the quality and order of the pesticide market, benefiting leading companies with multiple registration certificates [6] - CITIC Securities maintains a positive outlook on the home appliance industry, driven by government subsidies and increased demand for air conditioning during summer [7] Group 3 - Infomedia has agreed to be acquired by TPG for approximately 421.4 million USD, with a 30% premium over its recent stock price [8] - A breakthrough in the development of a 6mm thick rare earth permanent magnet motor has been achieved, marking a significant advancement in high-end motor technology [9] - The film "Nanjing Photo Studio" has surpassed 1.7 billion RMB in box office revenue, indicating strong audience reception [10] Group 4 - Researchers have reduced the number of codons in E. coli from 64 to 57, potentially opening new avenues for drug and material development [11] - OpenAI has released two open-weight AI models capable of mimicking human reasoning, marking a significant step in AI accessibility [12] - JD Coin Chain is preparing to apply for a stablecoin license in Hong Kong, countering rumors of withdrawal from the market [13]

Core Viewpoint - Meibang Co., Ltd. (605033) experienced a significant stock price surge, with a two-day increase of 21%, reaching a total market capitalization of 3.2 billion yuan, despite ongoing shareholder reductions in holdings [1][2] Group 1: Stock Performance and Trading Activity - Meibang Co., Ltd. achieved consecutive trading limits on July 17 and July 18, with a total trading volume of approximately 46 million yuan and over 220,000 shares still on the buy limit at the close [1] - During the price surge, there were substantial block trades, totaling approximately 28.84 million yuan and 1.544 million shares, with an estimated average transaction price of 18.68 yuan per share, which is over 20% lower than the closing price of 23.36 yuan [1] - The company confirmed that the recent shareholder reductions were consistent with previously disclosed plans and did not constitute illegal trading [1][2] Group 2: Shareholder Reduction Plans - Shareholders, including Meiping Consulting and Hao Xinxin, had announced a reduction plan on June 4, with maximum reduction ratios of 0.92%, 1.29%, and 0.79%, using centralized bidding or block trading from June 26 to September 25 [2] - The company conducted a self-examination and confirmed that there were no undisclosed significant information beyond what had been previously announced [2] Group 3: Business Overview and Market Conditions - Meibang Co., Ltd. specializes in pesticide products, including active ingredients like quinoline copper and insecticides, and is ranked among the top 100 pesticide sales companies in China [2] - Despite being a leading player in the pesticide industry, the overall market is still in a deep adjustment phase, with expected declines in net profit for 2024 and the first quarter of 2025 [2] - The company has experienced multiple stock price fluctuations this year, including a notable 133% increase from January 2 to January 16, reaching a peak price of 32.86 yuan per share [3]

Industry Overview - The pesticide industry in 2024 is under pressure but maintains stable development due to food security demands, showcasing trends in technological innovation and green transformation [2] - China, as the largest pesticide producer and exporter, is seeing an increase in technical capabilities and product variety, with top domestic companies experiencing revenue growth [2] - The upcoming "one certificate, one product" policy is expected to enhance industry standardization and sustainable development [2] Product Pricing and Trends - Current prices for key products are: - Abamectin: 515,000 CNY/ton - Methomyl: 720,000 CNY/ton - Bacillus thuringiensis: 27,000 CNY/ton - Prices are expected to rise, influenced by raw material costs and seasonal demand [3] Core Competencies - The company has strong resilience during industry downturns and has initiated cost-reduction strategies [3] - Production capacity includes: - Active ingredient capacity: 110,200 tons - Formulation capacity: 132,700 tons - The company holds 296 domestic pesticide registrations and 2,770 overseas registrations, indicating a robust product structure [3][5] Strategic Planning for 2025 - Focus on quality and cost efficiency for key products like Abamectin and Methomyl [6] - Enhance brand influence and market presence through new marketing strategies [6] - Accelerate international expansion, particularly in South America and Southeast Asia [6][8] - Drive research and development efficiency, emphasizing innovative product development [6] Financial Performance - In 2024, the company reported: - Revenue: 4.237 billion CNY, a 0.32% increase - Net profit: 81.36 million CNY, a 31.11% increase - Non-recurring net profit: 51.18 million CNY, a 12.52% increase [10] R&D and Innovation - The company is a pioneer in the industrial development of Abamectin and Methomyl, with a comprehensive product chain [5][13] - In 2024, the company established a synthetic biology laboratory to enhance product development capabilities [7][13] - New product projects are progressing, with 15 new patents granted in 2024 [8] Market Expansion and Risk Management - International revenue accounts for 33.89%, primarily from South America, Southeast Asia, and Africa [11] - The company employs financial derivatives to hedge against foreign exchange risks [11] - The impact of the US-China tariff conflict is minimal, with less than 2% of exports affected [16]